Trials / Completed
CompletedNCT00400218
Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)
Evaluate the Safety and Tolerability of Hyzaar(R) (Losartan 50 Mg/ Hydrochlorothiazide 12.5 Mg) In the Treatment of Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety and anti-hypertensive efficacy of hyzaar(R) in patients with mild to moderate essential hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-19
- First posted
- 2006-11-16
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00400218. Inclusion in this directory is not an endorsement.